Search Results - "Zöllner, Y."

Comparison of NITAG policies and working processes in selected developed countries by Ricciardi, G.W, Toumi, M, Weil-Olivier, C, Ruitenberg, E.J, Dankó, D, Duru, G, Picazo, J, Zöllner, Y, Poland, G, Drummond, M

“…Highlights • NITAG recommendation is critical for vaccine market access. • Comparison of NITAG policies was performed in 13 selected developed countries. •…”
Get full text

Literature Review of Instruments to Assess Health-Related Quality of Life during and after Menopause by Y. F. Zöllner, C. Acquadro, Schaefer, M.

“…Background and objectives: Menopause is a physiological event occurring in women at about the age of 50. It signals the end of the reproductive years and is…”
Get full text

Budesonide + formoterol delivered via Spiromax® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler by Lewis, A., Torvinen, S., Dekhuijzen, P.N.R., Chrystyn, H., Melani, A., Zöllner, Y., Kolbe, K., Watson, A.T., Blackney, M., Plich, A.

“…Fixed-dose combinations of inhaled corticosteroids and long-acting β2 agonists are commonly used for the treatment of asthma and COPD. However, the most…”
Get full text

Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life by D'Haese, Jan G, Ceyhan, Güralp O, Demir, Ihsan Ekin, Layer, Peter, Uhl, Waldemar, Löhr, Matthias, Rychlik, Reinhard, Pirilis, Konstantinos, Zöllner, York, Gradl, Birgit, Foerster, Douglas, Möbius, Julia, Henniges, Friederike, Friess, Helmut

“…Exocrine pancreatic insufficiency (EPI) is frequent in patients with chronic pancreatitis (CP). This 1-year, prospective, multicenter, observational, disease…”
Get full text

PCV53 COST-UTILITY ANALYSIS OF EPROSARTAN COMPARED TO ENALAPRIL AND RAMIPRIL IN THE TREATMENT OF MODERATE TO SEVERE HYPERTENSION IN SWEDEN by Lindgren, P, Schwander, B, Zöllner, Y, Jönsson, B

Get full text

Cost-effectiveness of prophylaxis and treatment of influenza by Rychlik, R, Heinen-Kammerer, T, Rusche, H, Piercy, J, Scuffham, P, Zöllner, Y

Get more information

Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion by Kulik, Laura, da Fonseca, Leonardo G, He, Aiwu Ruth, Rimola, Jordi, Wilson Woods, Andrea, Zöllner, York F, Galle, Peter R

“…A virtual expert roundtable was convened on April 16, 2020, to discuss the evolving landscape of care for treating patients with advanced hepatocellular…”
Get full text

Cost-Utility Analysis of Eprosartan Compared to Enalapril in Primary Prevention and Nitrendipine in Secondary Prevention in Europe—The HEALTH Model by Schwander, Björn, BSc, Gradl, Birgit, MSc, Zöllner, York, PhD, Lindgren, Peter, PhD, Diener, Hans-Christoph, MD, Lüders, Stephan, MD, Schrader, Joachim, MD, Villar, Fernando Antoñanzas, PhD, Greiner, Wolfgang, PhD, Jönsson, Bengt, PhD

“…ABSTRACT Objective To investigate the cost-utility of eprosartan versus enalapril (primary prevention) and versus nitrendipine (secondary prevention) on the…”
Get full text